Report editions
This release
National Cervical Screening Program monitoring report 2023
Australian Institute of Health and Welfare (2023) National Cervical Screening Program monitoring report 2023, AIHW, Australian Government, accessed 25 October 2024. doi:10.25816/d4r6-h445
Australian Institute of Health and Welfare. (2023). National Cervical Screening Program monitoring report 2023. Canberra: AIHW. doi:10.25816/d4r6-h445
Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2023. AIHW, 2023. doi:10.25816/d4r6-h445
Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2023. Canberra: AIHW; 2023. doi:10.25816/d4r6-h445
Australian Institute of Health and Welfare 2023, National Cervical Screening Program monitoring report 2023, AIHW, Canberra. doi:10.25816/d4r6-h445
PDF | 2Mb
This is the fifth report to monitor the National Cervical Screening Program since it introduced 5-yearly HPV tests in December 2017. In 2018–2022, there were more than 5.2 million participants aged 25–74, and in 2022, 10% of screening HPV tests performed were positive for HPV types that cause cervical cancer. Cervical cancer incidence and mortality remained low at 11 new cases and 2 deaths per 100,000 women, respectively.
More than 5.2 million cervical screening participants aged 25–74 in 2018–2022
Cervical screening HPV test positivity was 10% in 2022
869 females aged 25–74 were diagnosed with cervical cancer in 2019
179 females aged 25–74 died from cervical cancer in 2021
National Cervical Screening Program monitoring report 2023